圣诺生物涨5.13%创近4年新高政策与资金共振推动股价上行

智选洞察2025-07-16

圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。但随后市场风格切换至大盘蓝筹，7月2日沪深300主力资金单日净流出32.57亿元，医药板块遭遇分流，公司随后三个交易日...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551112986?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-16 13:38","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551112986","market":"sh","top_or_hot":-1,"title":"圣诺生物涨5.13%创近4年新高 政策与资金共振推动股价上行","media":"智选洞察","content":"<div>\n<p>圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。但随后市场风格切换至大盘蓝筹，7月2日沪深300主力资金单日净流出32.57亿元，医药板块遭遇分流，公司随后三个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>圣诺生物涨5.13%创近4年新高 政策与资金共振推动股价上行</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n圣诺生物涨5.13%创近4年新高 政策与资金共振推动股价上行\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-16 13:38 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。但随后市场风格切换至大盘蓝筹，7月2日沪深300主力资金单日净流出32.57亿元，医药板块遭遇分流，公司随后三个交易日...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b","article_id":"2551112986","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716133818a44de70e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551112986","pubTimestamp":1752644288,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。研发转化与估值锚的再平衡长期看，圣诺生物的核心竞争力在于创新药研发转化及全球化布局。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688117":"圣诺生物","BK0239":"医药制造"},"translate_title":"Sino Biologics rose 5.13%, hitting a new high in nearly 4 years, and the resonance of policies and funds pushed the stock price up","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688117":1},"content_text":"圣诺生物股价今日大幅上涨，截至13点37分，最新价报40.34元/股，上涨5.13%，创近4年新高，并成功突破40元整数关口。政策与资金共振下的价值重估圣诺生物近期净流入受政策与资金面双重驱动。7月1日创新药支持政策出台后，单日主力资金净流入达3912万元，推动股价单日涨幅超6%。但随后市场风格切换至大盘蓝筹，7月2日沪深300主力资金单日净流出32.57亿元，医药板块遭遇分流，公司随后三个交易日累计净流出超3600万元。业绩预告显示，2025年上半年净利润同比预增253%-332%，叠加7月11日主力资金再度净流入691万元，政策红利与业绩高增形成短期催化。截至7月16日，公司主力资金累计净流入1557.6万元，显示多空博弈加剧。研发转化与估值锚的再平衡长期看，圣诺生物的核心竞争力在于创新药研发转化及全球化布局。2024年前三季度研发投入同比增长18%，3款1类新药进入临床Ⅱ期，创新药收入占比持续提升至科创板前列。境外收入占比达32.52%，多肽原料药业务成为利润增长引擎，驱动2025年上半年净利润增幅位列科创板第二。国泰君安指出，若核心产品临床进展顺利，中期或挑战40元压力位，对应动态市盈率约53倍。但当前78.90倍动态市盈率显著高于行业中枢，叠加GLP-1等赛道竞争加剧，未来需关注政策红利与业绩兑现的匹配度。技术面看，股价突破年线后量能放大，但高位换手率攀升至5.51%，需警惕资金分歧引发的波动风险。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551112986","isCrawlerRequest":true}

圣诺生物涨5.13%创近4年新高 政策与资金共振推动股价上行

精彩评论

圣诺生物涨5.13%创近4年新高政策与资金共振推动股价上行